Detalles de la búsqueda
1.
Exposure-response relationships for the efficacy and safety of filgotinib and its metabolite GS-829845 in subjects with rheumatoid arthritis based on phase 2 and phase 3 studies.
Br J Clin Pharmacol
; 88(7): 3211-3221, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35072287
2.
Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir.
Gastroenterology
; 151(3): 501-512.e1, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27296509
3.
Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus.
Hepatology
; 61(1): 41-5, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25314116
Resultados
1 -
3
de 3
1
Próxima >
>>